Globally, the incidence rates of inflammatory bowel disease (IBD) are increasing; however, data from high-incidence areas are conflicting. Previous studies in Denmark have assessed incidence rates of Crohn's disease (CD) and ulcerative colitis (UC) using short observation periods.
SUMMARY Background
Globally, the incidence rates of inflammatory bowel disease (IBD) are increasing; however, data from high-incidence areas are conflicting. Previous studies in Denmark have assessed incidence rates of Crohn's disease (CD) and ulcerative colitis (UC) using short observation periods.
Aim
To investigate trends in IBD incidence in Denmark over a thirty-year period using nationwide data.
Methods
Patients diagnosed with CD or UC in Denmark between 1980 and 2013 were identified in the Danish National Patient Registry (NPR) and included in a nationwide cohort. Incidence rates estimated using different numbers of National Patient Registry records (≥1, 2, 3 or 4) required for case definition were compared.
Results
From 1980 to 2013 the incidence of CD increased from 5.2 (95% CI: 5.0-5.4) per 100 000 to 9.1 (95% CI: 8.7-9.5) per 100 000 and the incidence of UC increased from 10.7 (95% CI: 10.4-11.0) per 100 000 to 18.6 (95% CI: 18.0-19.2) per 100 000. The increased incidence in CD and UC was independent of gender. The annual increase in incidence rate was greatest in patients aged <15 years for CD and those older than 15 years for UC. For both CD and UC the incidence rates for females were significantly higher than for males. The number of registry records chosen to define IBD cases greatly influenced incidence estimates.
Conclusions
The incidence of IBD in Denmark continues to increase and is among the highest in the world. Using at ≥2 records of IBD diagnosis in the Danish National Patient Registry will result in more valid incidence estimates.
Aliment Pharmacol Ther 2017; 45: 961-972
INTRODUCTION
The incidence of inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is increasing worldwide in both the adult 1 and paediatric 2 populations, affecting between 0.3 and 0.8%
of the total population in Europe alone. 3 Denmark has among the highest incidence of IBD in the world 1, 4 and research indicates that it continues to rise. [5] [6] [7] In light of its universal and standardised health care, the routine registration of life and health care data for more than 30 years, and the possibility of exact individual-level linkage, Denmark offers excellent conditions for epidemiological research. Epidemiological studies of IBD using population-based cohorts have been performed in Denmark since the 1950s 8 and have relied on the Copenhagen Diagnostic Criteria for IBD. 9, 10 Nationwide health registry-based cohorts, on the other hand, have relied on alternative criteria to define incident cases based on records of an IBD diagnosis in the Danish National Patient Register (NPR), with many outcome-related studies requiring only a single record for case definition. 11, 12 While avoiding time-and location-based variations in incidence rates, the accuracy of registry-based research is dependent on the ability to accurately identify cases of IBD. Recent studies have indicated that incidence estimates from manually collected cohorts differ from estimates made according to the NPR. 4, 5, 7, 13 These differences may be caused by geographic or temporal variations, or by discrepancies in case definition. The direct and indirect health care burden of managing IBD is substantial, 14, 15 meaning that accurate estimates of incidence and trends are essential for health care providers and patients alike. No previous study has investigated the long-term trends in overall, as well as gender-and age-specific, IBD epidemiology in Denmark. Hence, with the present study our objectives were (i) to describe the incidence of IBD in Denmark in the period 1980-2013, as well as the differences among gender and age groups, based on nationwide data, and (ii) to investigate the influence of case definitions in the Danish health registry on estimated incidence rates, in order to make recommendations for future research.
MATERIALS AND METHODS
Data source and study population The date of diagnosis was defined as the date of the first record of any IBD diagnosis for an in-patient or out-patient hospital contact. When using criteria with at least two, three or four records of UC or CD in the NPR in the period 1980-2013 the date of the first record was used as the date of diagnosis. For patients who received a diagnosis of both UC and CD during their disease course we applied the rule that patients were included under their first disease registered. 7 For example, when using the criterion of at least two records of UC in the NPR, we first searched for patients with at least two records of UC in the NPR and identified the date of the first of these. We then checked whether these patients also had at least two records of CD in the NPR, and if so we identified the date of the first of these. If the date of the first CD record was prior to the date of the first UC record then the patient was not included as a UC case.
Statistical analysis
The incidence rates for UC and CD were presented as the incidence rates per 100 000 person years and were estimated as the number of patients multiplied by 100 000, divided by the number of inhabitants at the mid-point of the same calendar year. Poisson regression was applied to test for differences in the incidence rates of CD and UC for men and women, as well as for differences among the various criteria. The multivariable model applied included gender and used criterion and calendar time in 2-year periods as categorical explanatory variables. Within this model a natural spline function with five knots was used to fit the nonlinear effect of age. This choice was made after applying Poisson models with different numbers of knots, and finding by visual inspection that choosing five knots serves as a good compromise between over-and under fitting the relationship with age. The natural logarithm of the person years was included as an offset. A likelihood ratio test was used to test for differences between men and women, and Tukey's approach for multiple comparisons was used to make pairwise comparisons of the criteria.
The prevalence of IBD was calculated based on the estimated incidence rates across years, age groups and gender when using at least two records as the criterion for case definition and corresponding uncertainties [a standard deviation (s.d.) of 0.1 for CD and 0.2 for UC].
The number of years spent coping with the disease for patients in Denmark was assumed to follow a normal distribution, with a mean of 40 years and a standard deviation of 15 years for CD and a mean of 35 years with a standard of 15 years for UC. These values were based on the difference between the average life expectancy in Denmark and the average age at time of diagnosis. In our dataset the average age at time of diagnosis was approximately 40 years for CD for both men and women and approximately 45 years for UC for both men and women. The size of the Danish population was assumed to be 5.6 million. Through simulation the expected number of CD and UC patients in Denmark was estimated with a corresponding measure of uncertainty.
Ethical considerations
The study was approved by the Danish Data Protection Agency (J.nr.: 2014-41-3538). According to Danish law registry studies do not require ethical approval.
RESULTS

Incidence of CD and UC in Denmark 1980-2013
A total for 46 421 IBD patients [UC: 32 439 (70%), CD: 13 982 (30%)] with at least two IBD recordings in the NPR were included in the overall calculations. Median time between the first two recordings was 430 days for CD with no gender difference. For UC the median time between the first two recordings was 619 days for men and 654 days for women.
The overall incidence of IBD in Denmark between 1980 and 2013 was 25.9 (95% CI: 25.7 -26.1) per 100 000 person years, 7.8 (95% CI: 7.6 -7.9) per 100 000 person years for CD, and 18.0 (95% CI: 17.8 - Table S1 . The incidence rate for CD increased steadily throughout the observation period from 5.2 (95% CI: 5.0 -5.4) per 100 000 person years between 1980 and 1989, to 9.1 (95% CI: 8.7 -9.5) per 100 000 person years between 2010 and 2013 -equivalent to an annual increase of incidence rate of 2.1%. This observation was true for both women [increasing from 6.3 (95% CI: 6.0 -6.7) per 100 000 person years to 9.7 (95% CI: 9.2 -10.3) per 100 000 person years] and men [increasing from 4.1 (95% CI: 3.8 -4.3) per 100 000 person years to 8.4 (95% CI: 7.8 -8.9) per 100 000
person years]. Similar to CD, the incidence rate for UC increased throughout the observation period from 10.7 (95% CI: 10.4 -11.0) per 100 000 person years in 1980-1989 to 18.6 (95% CI: 18.0 -19.2) per 100 000 person years in 2010-2013, with an annual increase of incidence rate of 2.1%. In women the incidence rate of UC increased from 11.2 (95% CI: 10.8 -11.6) per 100 000 person years to 18.6 (95% CI: 17.8 -19.4) per 100 000 person years, while in men it increased from 10.2 (95% CI: 9.8 -10.6) per 100 000 person years to 18.6 (95% CI: 17.8 -19.4) per 100 000 person years. Incidence curves for the various criteria used for case definitions are shown in the Figures S1 and S2. Figure 2 shows the incidence rates of CD and UC for females and males as a function of age in 1-year intervals. In CD, the incidence rates for both females and males peaked between the ages of 20 and 25 years, but with females exhibiting almost twice as high incidence rates as compared to males, and independently of the criterion used for case definition ( Figures S3 and S4) . In UC incidence rates peaked later than CD at the age of 25-35 years with a slightly higher incidence rate for females than for males. The incidence rates for both females and males remain high after the age of 35, with a slight decrease at the age of 40-60 years, followed by a slight increase for 60 years old and above. These patterns are also described in Table S2 , where age is divided into the groups <15, 15-29, 30-44, 45-59, 60-74 and ≥75 years old. Poisson regression was applied to test for differences in the incidence rate of CD and UC for men and women. For both CD and UC, the incidence rates for females were significantly higher than for males across age and calendar time (P < 0.0001 with estimated relative risks being 1.35 for CD and 1.08 for UC. Additionally, we applied Poisson regression to subgroups defined by the same categorisation of age as Crohn's disease Males Females
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Ulcerative colitis 1 9 8 0 -1 9 8 1 1 9 8 2 -1 9 8 3 1 9 8 4 -1 9 8 5 1 9 8 6 -1 9 8 7 1 9 8 8 -1 9 8 9 1 9 9 0 -1 9 9 1 1 9 9 2 -1 9 9 3 1 9 9 4 -1 9 9 5 1 9 9 6 -1 9 9 7 1 9 9 8 -1 9 9 9 2 0 0 0 -2 0 0 1 2 0 0 2 -2 0 0 3 2 0 0 4 -2 0 0 5 2 0 0 6 -2 0 0 7 2 0 0 8 -2 0 0 9 2 0 1 0 -2 0 1 1 2 0 1 2 -2 0 1 3 1 9 8 0 -1 9 8 1 1 9 8 2 -1 9 8 3 1 9 8 4 -1 9 8 5 1 9 8 6 -1 9 8 7 1 9 8 8 -1 9 8 9 1 9 9 0 -1 9 9 1 1 9 9 2 -1 9 9 3 1 9 9 4 -1 9 9 5 1 9 9 6 -1 9 9 7 1 9 9 8 -1 9 9 9 2 0 0 0 - mentioned above. For UC, statistical significant differences between men and women were found with relative risks ranging from 1.24 for the 15 to 29 years groups to 0.84 for the group above 75 years. For CD statistical significant differences between men and women were also found for all age groups with relative risks ranging from 1.54 for the 15 to 29 years groups to 0.82 for the group below 15 years. We also performed Poisson models with age, calendar time and age as categorical explanatory variables. For age the categories were as defined as <15, 15-29, 30-44, 45-59, 60-74 and ≥75 years. Tukey's approach for multiple comparisons was used to make pairwise comparisons of the different age groups. For UC statistical significant differences were found for all combinations of age groups. For CD statistical significant differences were also found for all combinations of age groups except for the difference between the 45 and 59 and the 60-74 years age groups. Figure 3 shows incidence rates over time according to different age groups. The observed increases in incidence rates for CD and UC occurred in all age groups; however, they were most notable for patients aged 15-44 for CD and for those older than 15 years for UC, independent of the criterion used for case definition ( Figures S5  and S6 ). Annual increases in incidence rates 1980-2011 were analysed for the age groups <15 years, 15-44 years, 45-60 years and ≥60 years. In CD the annual increase in incidence rate in this period was 6.2%, 1.9%, 0.3% and 1.9%, respectively. In UC, the annual increases in incidence rates was 1.0%, 2.2%, 2.0% and 2.0%, respectively.
Impact of criteria on incidence estimates
As shown in Figure 4 and Tables S1 and S2, the number of patients included, as well as incidence rates for CD and UC, differed significantly according to the various criteria applied for case definitions, with at least one record in NPR leading to much higher incidence rates than a minimum of two, three or four records, although the difference between at least one and at least two records was less pronounced for UC than for CD. Decreasing incidences were seen after 2009 when using ≥2 records in NPR as the criterion for case definition because a patient with first time diagnosis at the end of the study period has a smaller chance of fulfilling these criteria as compared to a patient diagnosed earlier. This is supported by the observation that the decrease was steeper and occurred earlier for each additional IBD record that was required for case definition (Figure 4) . Thus, when using criteria based on more than one IBD record, the prior 25 years of the study period depending on the criterion used should not be included due to the risk of underestimating the number of patients. The same observations were made for age-and gender-specific incidence rates. In particular, incidence rates in the ≥60 years old group differed substantially between the criteria using at least one record and those requiring ≥2 records ( Figures S5 and S6 ). Poisson regression was applied to test for differences in the incidence rates between the various criteria. The comparisons of the criteria used for case definition were performed using Tukey's approach for multiple comparisons within the Poisson regression model. For both CD and UC there were significant differences between all four sets of criteria (P < 0.0001).
Estimated prevalence of IBD in Denmark in 2013
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DISCUSSION
The incidence of IBD is subject to considerable variation worldwide, both between and within geographic regions. While temporal trend analyses have shown that global incidence rates of IBD have increased throughout the twentieth century data from the previous two decades are conflicting, with some studies demonstrating a continuous increase and others a decrease in incidence. 1 Here, we present comprehensive long-term temporal trends in IBD incidence in Denmark using nationwide data. We have shown that the incidence of both CD and UC has increased steadily since the 1980s until 2013, with incidence rates rising from 5. 1 9 8 0 -1 9 8 1 1 9 8 2 -1 9 8 3 1 9 8 4 -1 9 8 5 1 9 8 6 -1 9 8 7 1 9 8 8 -1 9 8 9 1 9 9 0 -1 9 9 1 1 9 9 2 -1 9 9 3 1 9 9 4 -1 9 9 5 1 9 9 6 -1 9 9 7 1 9 9 8 -1 9 9 9 2 0 0 0 -2 0 0 1 2 0 0 2 -2 0 0 3 2 0 0 4 -2 0 0 5 2 0 0 6 -2 0 0 7 2 0 0 8 -2 0 0 9 2 0 1 0 -2 0 1 1 2 0 1 2 -2 0 1 3 1 9 8 0 -1 9 8 1 1 9 8 2 -1 9 8 3 1 9 8 4 -1 9 8 5 1 9 8 6 -1 9 8 7 1 9 8 8 -1 9 8 9 1 9 9 0 -1 9 9 1 1 9 9 2 -1 9 9 3 1 9 9 4 -1 9 9 5 1 9 9 6 -1 9 9 7 1 9 9 8 -1 9 7 The present study is, however, the first to examine temporal trends using the full observation time available in the Danish NPR, which is among the most comprehensive in the world. 17 Our findings confirm that the incidence of IBD continues to increase in Denmark. This finding is in accordance with recent observations in other high-incidence areas such as France, 25 Spain, 26 Canada 27 and our neighbouring Scandinavian countries, [28] [29] [30] [31] [32] as well as in previous low-incidence areas of Eastern Europe 4, 33 and Asia. 34 Possible explanations for the observed increase in incidence include heightened disease awareness among physicians and patients, and improvements in diagnosing IBD. 35, 36 However, the fact that we could not observe any sudden or steep increase in IBD incidence makes this less likely. Awareness of IBD is high among physicians in Denmark. The first Danish IBD clinics were established in 1952 and the first database of IBD patients in 1958. 37 Furthermore, as the Danish health care system is public and offers free access to medical care, it can be assumed that all patients with symptoms of IBD are seen by a physician. There is a longstanding tradition of general practitioners and private practicing gastroenterologists referring patients with suspected IBD to public hospitals for diagnosis and treatment and only rarely are patients treated for their IBD outside of the public health care sector. 5 Changes in life-style and environmental factors over time might therefore be the true reason for the continuous increase in incidence. Smoking is one the best described risk factors in IBD, however, the prevalence of smokers in Denmark is low at 22% of the Danish population and the prevalence of smokers has been declining since the 1970s. 38 On the other hand, the use of antibiotics in children has increased over the last decades 39 and the Danish population has become more obese, less physical active and is eating less healthy food according to recommendations of the health authorities. 40, 41 The former factors have all been linked to an increased risk for developing IBD and could have contributed to the observed temporal trend. Yet while multiple environmental and host risk factors have been implicated in IBD pathogenesis, none of them appear to fully explain the pathogenesis of IBD. 42 Incidence rates for CD and UC peaked in the age interval 20-35 years in both females and males, with a less pronounced peak in UC incidence after the age of 60 years. The bimodal distribution for UC is in accordance with other cohorts, 28, [43] [44] [45] however, is not a consistent finding throughout the literature 1 and this observation must be taken with caution as ischaemic or microscopic colitis might have been misinterpreted as IBD. The second peak in UC incidence in fact attenuates with increasing number of IBD diagnoses in the NPR required for case definition. Regarding gender distribution, we found a female predominance in CD as well as, although much smaller, in UC. Several prospective population-based studies from high-incidence areas have reported the same gender difference in CD. 9, 43, 46 However, in a recent systematic review no gender difference in IBD incidence was found as female-to-male ratios varied from 0.51 to 1.58 for UC studies and 0.34-1.65 for CD studies. 1 Gender differences in CD observed in this study were age-dependent as the female incidence curve only separated from males shortly after puberty at the age of 15 and remained higher until approximately 45 years. Only a few cohorts have previously examined gender differences across ages, but similar observations have been made in both European and North American cohorts. 46, 47 The age-specific difference in CD gender distribution suggests that cumulative exposure to oestrogen following puberty may play a part in the development of CD. Oestrogen is hypothesised to play an important role in the pathogenesis of CD by causing alterations in intestinal permeability and immune function, although its precise action is yet to be determined. 48, 49 Furthermore, exogenous hormones used for oral contraception increase the risk of CD and are associated with a worsened disease course in young, premenopausal women. 50, 51 Interestingly, postmenopausal hormone therapy did not appear to increase the risk for CD in a recent cohort study. 52 Finally, we compared the influence of four different sets of criteria for case definition on incidence rates. The number of registry records chosen to define IBD cases greatly influenced the number of patients identified, and thus incidence estimates. Most striking was the difference between using 1 and ≥2 records, suggesting that reliance on only one IBD record in the NPR will greatly overestimate the number of IBD patients. In accordance, a recent validation of IBD diagnosis in the Swedish NPR found that a substantial proportion of patients with only one record of IBD diagnosis do not have IBD. 53 Previous population-based studies on IBD incidence in Denmark have used the Copenhagen Diagnostic Criteria 9, 10 for IBD case definition and have been performed in the Copenhagen City and County area, 4, 5, 9, 10, 23 while one study investigated incidence rates in North Jutland County. 6 Compared to findings from these previous studies, using at least two or three NPR records for case definition in the present nationwide cohort results in the greatest similarity. For example, incidence rates between 1991 and 1993 in Copenhagen City and County were 6.6 per 100 000 for CD and 10.0 per 100 000 for UC, 23 while they were 8.6 per 100 000 for CD and 13.4 per 100 000 for UC in 2003-2004. 5 However, such a comparison of incidence rates is limited by the fact that only two regions in Denmark have reported on IBD incidence in the past. Incidence rates seem to vary substantially between regions in Denmark. In a recent study, the reported incidence rates in 2010 of six Danish centres located all over Denmark varied between 5.2 and 10.7 per 100 000 for CD and 7.5-18.7 per 100 000 for UC, depending on the region. 54 Establishing the best set of criteria for registries such as the Danish NPR is a trade-off between over-and underestimating the true number of patients. The previous validation of IBD diagnosis in the NPR did not include out-patient visits 18 which might have increased misclassification of ICD codes. Future studies validating IBD diagnosis and that include validation across age groups are therefore needed. Based on the present study findings, however, we believe that using at least two records of IBD diagnosis for case definition, as well as excluding the most recent 2 years of observation, will result in more accurate estimates of incidence. This requirement of at least two IBD records as case definition criteria is in line with two recent studies from large patient registries from Sweden 55 and Hungary. 56 Finally, when preparing studies based on NPR the fact that the number of incident patients decreases in the most recent observation years when requiring more than one record in the NPR should be taken into consideration. Our study has several strengths. First and foremost, the data derive from a large, well-defined population with nationwide coverage. The Danish NPR is among the most comprehensive health care registries in the world 17 and includes both in-and out-patient contacts.
IBD diagnoses in the NPR have previously been validated and found to be of high completeness and validity. 18 The inclusion of out-patient visits since 1995 can only be assumed to increase the completeness of IBD registration. As Denmark offers free and easy access to health care for all residents, independent of ethnicity and socio-economic status, we are confident that we have used a complete and unselected population of IBD patients. Using nationwide data makes our observations independent of regional differences in practice patterns, exposures, and genetic susceptibility. Second, despite the high validity of the NPR regarding IBD diagnosis we required at least two records of an IBD diagnosis as case definition criteria for incidence analysis. Third, for the first time we have investigated temporal trends in IBD incidence as well as differences across age groups and gender over three decades, allowing for a comprehensive and long-term picture of IBD in Denmark. Limitations to our study include the fact that the NPR only includes out-patient visits since 1995 and that the first recording of IBD in the NPR in some patients might not be the correct date of diagnosis Furthermore, data on differences in risk factors for IBD, i.e. smoking were not available for the study, and data on disease classification are not recorded in the NPR and thus temporal trends not possible to assess. Given that the predictive value of IBD diagnosis in the NPR is not 100% accurate, we will likely have overestimated incidence rates somewhat. Finally, data on deaths were not available for this study, which would have made prevalence estimates more accurate. To conclude, in this large, nationwide and unselected cohort of IBD patients we have demonstrated that the incidence of IBD has increased continuously over the last three decades. The increasing incidence rate combined with compounding prevalence indicate that the number of patients with IBD living in Denmark will likely increase significantly in the decades to come and thus constitute a significant burden for the Danish health care system. Future studies on IBD using the Danish nationwide registries should rely on at least two records of an IBD diagnosis and they should exclude the immediate years preceding the observation period in order to avoid overrepresentation of cases.
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